| Old Articles: <Older 3991-4000 Newer> |
|---|
 |
The Motley Fool
August 7, 2007
Brian Orelli |
Financing Your Acquisition Schering-Plough is one step closer to financing its $14 billion acquisition of the Organon BioSciences unit of Akzo Nobel, by making an official stock offering.   |
Popular Mechanics
August 2007
Barry Rosenberg |
For Rapid-Response in Iraq, Proven Surgical Tool Gets Makeover One biomedical company is developing new antibiotic beads for use in battlefield hospitals. |
Chemistry World
August 6, 2007
Victoria Gill |
Novartis Loses Indian Patent Law Case Swiss drug firm Novartis has lost its legal case against the Indian government, who it had accused of 'unconstitutional' patent law practices. The ruling sets an important precedent that will cheer the flourishing generics market in the country. |
The Motley Fool
August 6, 2007
Brian Orelli |
Cheap Drugs on the Farm The House approves a prescription-drug import provision. Investors should keep an eye on the status of the bill, because laws that hurt the drugmakers' bottom lines will hurt their stock prices as well. |
The Motley Fool
August 6, 2007
Brian Lawler |
Unhappy Delays for MannKind Two delays for the inhalable insulin developer cause the stock to drop. |
The Motley Fool
August 6, 2007
Brian Orelli |
Congress' Delay May Hurt Drugmakers The reauthorization of the Prescription Drug User Fee Act is delayed. If you're an investor in drug companies, now might be a good time to call your representatives and senators. |
The Motley Fool
August 6, 2007
Andrew R. Vaino |
NPS Pharmaceuticals: What's for Dinner? The small biotech pins its hopes on a drug that helps patients digest their food. Because the company's market cap is just $180 million, shares could jump significantly on a positive clinical result. |
The Motley Fool
August 6, 2007
Brian Orelli |
Hopeful Investors Stoke Pharmion's Price Clinical trials to get a drug approved for new uses usually don't have the gusto that trials for the original New Drug Application have, but Pharmion results released last week have blown the stock price through the roof. |
The Motley Fool
August 6, 2007
Billy Fisher |
WellCare Continues to Wow Investors who have stayed with managed-care provider WellCare this past year have been rewarded for their patience. The company reported a 136% year-over-year increase in earnings, and shares are up 98%. |
The Motley Fool
August 6, 2007
Billy Fisher |
Molina's Q2 Measures Up While earnings were relatively flat at Molina Healthcare, revenue growth and cost-cutting efforts are on the right track. |
| <Older 3991-4000 Newer> Return to current articles. |
